KM Research Hub
← 返回结果库查看论文详情PubMed ↗
READ-ONLY DIGITIZATION RESULT

Adjuvant Epirubicin Plus Cyclophosphamide Followed by Taxanes With or Without Carboplatin in Early-Stage Triple-Negative Breast Cancer (RJBC 1501): A Randomized Phase III Trial.

J Clin Oncol · 2026-Jan-20 · PMID 41365333

Panel B质量警告待 EXE 对齐验证

DFS

FIG A3. Kaplan-Meier plot of DFS curve stratified by (A) age at diagnosis and (B) HER2 status. HER2-low indicated tumors with HER2 IHC status 1+ to 2+. Cb, carboplatin; DFS, disease-free survival; EC-T, epirubicin plus cyclophosphamide followed by taxanes; EC-TCb, EC-T plus carboplatin; HER2, human epidermal growth factor receptor 2; IHC, immunohistochemistry.

算法:legacy-0.5.0引擎:enhanced-linux
质量评分0.29
质量通过否
预期曲线2
实际曲线1
X 范围-1 – 9.5
Y 范围0 – 0.75

曲线数据

网页最多预览 200 行,完整数据请下载 CSV 或 JSON。

匹配 13 行
Curve序号X (norm)Y (norm)X (real)Y (real)X (pixel)Y (pixel)
110.00000.6640-1.00000.4980186243
120.04210.6640-0.55780.4980260243
130.04270.6640-0.55180.4980261243
140.04330.6619-0.54580.4964262244
150.04380.6660-0.53980.4995263242
160.04440.6660-0.53390.4995264242
170.04500.6660-0.52790.4995265242
180.04550.6660-0.52190.4995266242
190.04610.3340-0.51590.2505267405
1100.04670.3238-0.51000.2429268410
1110.37560.34622.94420.2597846399
1120.37620.34622.95020.2597847399
1130.37680.17112.95620.1283848485
历史版本(1)

重跑只新增版本,不覆盖旧结果;正式可用状态仅授予通过 EXE 基准或人工复核的版本。

版本状态验证曲线时间
legacy-0.5.0quality_warning待验证12026-07-24T15:14:48+00:00